Skip to main content
. 2022 May 6;14(5):1001. doi: 10.3390/pharmaceutics14051001

Figure 33.

Figure 33

Kinase inhibitory activity of filgotinib, * indicates the IC50 and index selectivity values determined using recombinant JAKs, ** indicates the IC50 values determined using a human whole blood assay [116,117].